Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue
References (15)
- et al.
5-Hydroxytryptamine uptake by rat brain in vitro
Life Sci.
(1967) A simple efficient liquid scintillator for counting aqueous solutions in a liquid scintillation counter
Anal. Biochem.
(1960)- et al.
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine
European J. Pharmacol.
(1969) - et al.
Accumulation of tritiated 5-hydroxytryptamine in brain slices
Life Sci.
(1967) - et al.
Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents
European J. Pharmacol.
(1967) - et al.
Identification and assay of serotonin in brain
J. Pharmacol.
(1956) - et al.
Possible role of serotonin in brain function
J. Pharmacol.
(1956)
Cited by (290)
Cannabidiol and substance use disorder: Dream or reality
2022, NeuropharmacologyCitation Excerpt :CBD has also been shown to facilitate the neurotransmission mediated by the serotonin 1A receptor (5-HT1A). Serotonergic transmission is strongly implicated in substance abuse disorders, including addiction to substances such as cocaine, METH, amphetamine (AMPH), and morphine, which interfere with the functionality of monoamine transporters for serotonin, dopamine, and noradrenaline, leading to addiction-related behavior in humans and animals (Koe, 1976; Müller et al., 2007; Ross and Renyi, 1967, 1969). Serotoninergic neurons, which originate from the dorsal raphe nucleus (Ishimura et al., 1988), are involved in the modulation of reward-related behaviors (Luo et al., 2015; McDevitt et al., 2014).
The discovery of tricyclic antidepressants and their mode of action
2022, Discoveries in Pharmacology - Volume 1 - Nervous system and hormonesSerotonin neurobiology in cocaine use disorder
2020, Handbook of Behavioral NeuroscienceArousal and drug abuse
2019, Arousal in Neurological and Psychiatric DiseasesHow do antidepressants work? New perspectives for refining future treatment approaches
2017, The Lancet PsychiatryCitation Excerpt :The first clinically useful antidepressant medications were discovered serendipitously about 60 years ago.1 Subsequently, laboratory studies revealed that these drugs increased synaptic concentrations of serotonin and norepinephrine,2 and this action was hypothesised to underpin their antidepressant action. Decades later, a range of antidepressant drugs have been developed that, with few exceptions, act to enhance monoamine neurotransmission.